Boyd Watterson Asset Management LLC OH Sells 325 Shares of Colgate-Palmolive (NYSE:CL)

Boyd Watterson Asset Management LLC OH lowered its position in shares of Colgate-Palmolive (NYSE:CL) by 17.8% in the 4th quarter, HoldingsChannel reports. The firm owned 1,500 shares of the company’s stock after selling 325 shares during the quarter. Boyd Watterson Asset Management LLC OH’s holdings in Colgate-Palmolive were worth $120,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. OFI Invest Asset Management purchased a new position in Colgate-Palmolive during the 3rd quarter valued at about $25,000. Avion Wealth boosted its position in shares of Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares in the last quarter. McGlone Suttner Wealth Management Inc. bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth approximately $34,000. Kayne Anderson Rudnick Investment Management LLC lifted its position in Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares in the last quarter. Finally, West Branch Capital LLC lifted its position in Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after acquiring an additional 132 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CL shares. Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective on the stock in a research report on Monday, January 29th. The Goldman Sachs Group initiated coverage on Colgate-Palmolive in a research note on Friday, March 1st. They issued a “buy” rating and a $93.00 price target on the stock. Stifel Nicolaus raised their price target on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a “buy” rating in a research note on Wednesday, April 10th. UBS Group raised their target price on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. Finally, Wells Fargo & Company raised their target price on Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Trading Up 1.9 %

CL traded up $1.72 on Friday, hitting $91.01. The company had a trading volume of 7,541,541 shares, compared to its average volume of 3,968,951. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $92.25. The business’s fifty day simple moving average is $87.66 and its 200 day simple moving average is $81.46. The company has a market cap of $74.81 billion, a PE ratio of 32.74, a PEG ratio of 3.35 and a beta of 0.42. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter in the previous year, the business earned $0.73 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. Equities research analysts expect that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a $0.50 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. Colgate-Palmolive’s payout ratio is presently 71.94%.

Insider Activity at Colgate-Palmolive

In related news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Over the last quarter, insiders sold 232,371 shares of company stock worth $19,505,099. Company insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.